

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | signal peptide processing (GO:0006465) | 7.79563189 |
| 2 | protein maturation by protein folding (GO:0022417) | 7.16431900 |
| 3 | endocrine pancreas development (GO:0031018) | 6.78662150 |
| 4 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 6.42234369 |
| 5 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 6.34793683 |
| 6 | sequestering of metal ion (GO:0051238) | 6.10742096 |
| 7 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 5.91008853 |
| 8 | peptide hormone processing (GO:0016486) | 5.75912470 |
| 9 | COPII vesicle coating (GO:0048208) | 5.72754098 |
| 10 | protein retention in ER lumen (GO:0006621) | 5.43254033 |
| 11 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 4.99477118 |
| 12 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 4.73141742 |
| 13 | vesicle coating (GO:0006901) | 4.68897464 |
| 14 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.68671938 |
| 15 | ER overload response (GO:0006983) | 4.61464229 |
| 16 | positive regulation of nuclease activity (GO:0032075) | 4.59943721 |
| 17 | positive regulation of insulin secretion (GO:0032024) | 4.59102668 |
| 18 | glandular epithelial cell differentiation (GO:0002067) | 4.58274621 |
| 19 | type B pancreatic cell development (GO:0003323) | 4.44769783 |
| 20 | exocrine pancreas development (GO:0031017) | 4.33001034 |
| 21 | insulin secretion (GO:0030073) | 4.31269205 |
| 22 | regulation of nuclease activity (GO:0032069) | 4.20948944 |
| 23 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 4.16480095 |
| 24 | negative regulation of bone resorption (GO:0045779) | 4.03181892 |
| 25 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.01415678 |
| 26 | cellular response to topologically incorrect protein (GO:0035967) | 3.98567035 |
| 27 | cellular response to unfolded protein (GO:0034620) | 3.97529247 |
| 28 | glandular epithelial cell development (GO:0002068) | 3.97481024 |
| 29 | regulation of insulin secretion (GO:0050796) | 3.95885638 |
| 30 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.95661738 |
| 31 | peptidyl-asparagine modification (GO:0018196) | 3.93022752 |
| 32 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.90867974 |
| 33 | sequestering of actin monomers (GO:0042989) | 3.85798635 |
| 34 | ER-nucleus signaling pathway (GO:0006984) | 3.73168268 |
| 35 | cellular zinc ion homeostasis (GO:0006882) | 3.63053345 |
| 36 | ER to Golgi vesicle-mediated transport (GO:0006888) | 3.61949165 |
| 37 | protein N-linked glycosylation (GO:0006487) | 3.60521318 |
| 38 | intra-Golgi vesicle-mediated transport (GO:0006891) | 3.60299265 |
| 39 | regulation of peptide hormone secretion (GO:0090276) | 3.55965907 |
| 40 | replication fork processing (GO:0031297) | 3.53616425 |
| 41 | nitric oxide mediated signal transduction (GO:0007263) | 3.51376647 |
| 42 | positive regulation of peptide hormone secretion (GO:0090277) | 3.50435113 |
| 43 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.48689493 |
| 44 | regulation of peptide secretion (GO:0002791) | 3.47908650 |
| 45 | negative regulation of glycoprotein metabolic process (GO:1903019) | 3.47695947 |
| 46 | negative regulation of insulin secretion (GO:0046676) | 3.45551988 |
| 47 | negative regulation of norepinephrine secretion (GO:0010700) | 3.45169143 |
| 48 | chaperone-mediated protein transport (GO:0072321) | 3.43962178 |
| 49 | regulation of glucocorticoid secretion (GO:2000849) | 3.43180014 |
| 50 | proteasome assembly (GO:0043248) | 3.40140866 |
| 51 | presynaptic membrane assembly (GO:0097105) | 3.36819507 |
| 52 | positive regulation of peptide secretion (GO:0002793) | 3.32420958 |
| 53 | resolution of meiotic recombination intermediates (GO:0000712) | 3.29593240 |
| 54 | nucleoside diphosphate catabolic process (GO:0009134) | 3.28907903 |
| 55 | platelet dense granule organization (GO:0060155) | 3.26975924 |
| 56 | CENP-A containing nucleosome assembly (GO:0034080) | 3.23992378 |
| 57 | pseudouridine synthesis (GO:0001522) | 3.23216960 |
| 58 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.22465811 |
| 59 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.21630327 |
| 60 | NADH dehydrogenase complex assembly (GO:0010257) | 3.21630327 |
| 61 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.21630327 |
| 62 | chromatin remodeling at centromere (GO:0031055) | 3.21551295 |
| 63 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.21135555 |
| 64 | response to endoplasmic reticulum stress (GO:0034976) | 3.21121352 |
| 65 | DNA ligation (GO:0006266) | 3.20315269 |
| 66 | regulation of glucokinase activity (GO:0033131) | 3.20000426 |
| 67 | regulation of hexokinase activity (GO:1903299) | 3.20000426 |
| 68 | spermatid nucleus differentiation (GO:0007289) | 3.16014756 |
| 69 | regulation of hormone secretion (GO:0046883) | 3.12612296 |
| 70 | GDP-mannose metabolic process (GO:0019673) | 3.12190472 |
| 71 | interleukin-1-mediated signaling pathway (GO:0070498) | 3.12173612 |
| 72 | negative regulation of bone remodeling (GO:0046851) | 3.11531865 |
| 73 | epithelial cell fate commitment (GO:0072148) | 3.11338424 |
| 74 | centriole replication (GO:0007099) | 3.09487657 |
| 75 | anterograde synaptic vesicle transport (GO:0048490) | 3.08832978 |
| 76 | regulation of mitochondrial translation (GO:0070129) | 3.08396234 |
| 77 | detection of calcium ion (GO:0005513) | 3.05990984 |
| 78 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.04409800 |
| 79 | protein neddylation (GO:0045116) | 3.04208955 |
| 80 | Golgi organization (GO:0007030) | 3.04187275 |
| 81 | ganglioside metabolic process (GO:0001573) | 3.04004015 |
| 82 | cellular response to vitamin D (GO:0071305) | 3.02956942 |
| 83 | protein complex biogenesis (GO:0070271) | 3.02674290 |
| 84 | negative regulation of peptide hormone secretion (GO:0090278) | 3.02103992 |
| 85 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.99561796 |
| 86 | neural tube formation (GO:0001841) | 2.99267433 |
| 87 | Golgi vesicle transport (GO:0048193) | 2.98792420 |
| 88 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.98445715 |
| 89 | DNA damage response, detection of DNA damage (GO:0042769) | 2.98436258 |
| 90 | viral protein processing (GO:0019082) | 2.96311556 |
| 91 | presynaptic membrane organization (GO:0097090) | 2.96126924 |
| 92 | negative regulation of peptide secretion (GO:0002792) | 2.94595244 |
| 93 | cell wall macromolecule catabolic process (GO:0016998) | 2.93900976 |
| 94 | kinetochore assembly (GO:0051382) | 2.93644048 |
| 95 | zinc ion homeostasis (GO:0055069) | 2.93023872 |
| 96 | response to unfolded protein (GO:0006986) | 2.91733788 |
| 97 | astrocyte differentiation (GO:0048708) | 2.91472372 |
| 98 | peptide hormone secretion (GO:0030072) | 2.91239653 |
| 99 | response to topologically incorrect protein (GO:0035966) | 2.90927313 |
| 100 | glycosphingolipid catabolic process (GO:0046479) | 2.90442091 |
| 101 | regulation of peptide transport (GO:0090087) | 2.90248499 |
| 102 | positive regulation of hormone secretion (GO:0046887) | 2.88337356 |
| 103 | glycoside metabolic process (GO:0016137) | 2.87285000 |
| 104 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.86849404 |
| 105 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.86849404 |
| 106 | respiratory chain complex IV assembly (GO:0008535) | 2.86799956 |
| 107 | peptide secretion (GO:0002790) | 2.85901895 |
| 108 | response to hexose (GO:0009746) | 2.85377163 |
| 109 | virion assembly (GO:0019068) | 2.84861519 |
| 110 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.84061248 |
| 111 | negative regulation of catecholamine secretion (GO:0033604) | 2.82496679 |
| 112 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.81976611 |
| 113 | response to glucose (GO:0009749) | 2.79514116 |
| 114 | protein localization to cilium (GO:0061512) | 2.79421141 |
| 115 | DNA topological change (GO:0006265) | 2.78969357 |
| 116 | response to misfolded protein (GO:0051788) | 2.77620465 |
| 117 | neuron cell-cell adhesion (GO:0007158) | 2.76767855 |
| 118 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.76599744 |
| 119 | lactate metabolic process (GO:0006089) | 2.75868305 |
| 120 | eosinophil chemotaxis (GO:0048245) | 2.75630544 |
| 121 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.74143866 |
| 122 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.74125397 |
| 123 | meiosis I (GO:0007127) | 2.73666222 |
| 124 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.73473687 |
| 125 | negative regulation of tissue remodeling (GO:0034104) | 2.73469710 |
| 126 | peptide catabolic process (GO:0043171) | 2.71901606 |
| 127 | regulation of oxidative phosphorylation (GO:0002082) | 2.71871484 |
| 128 | response to monosaccharide (GO:0034284) | 2.70045826 |
| 129 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.68819468 |
| 130 | mannosylation (GO:0097502) | 2.68736591 |
| 131 | glycolipid catabolic process (GO:0019377) | 2.68565229 |
| 132 | iron-sulfur cluster assembly (GO:0016226) | 2.66017992 |
| 133 | metallo-sulfur cluster assembly (GO:0031163) | 2.66017992 |
| 134 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.64635476 |
| 135 | intraciliary transport (GO:0042073) | 2.64565398 |
| 136 | DNA double-strand break processing (GO:0000729) | 2.64234290 |
| 137 | maintenance of protein localization in organelle (GO:0072595) | 2.63723637 |
| 138 | macroautophagy (GO:0016236) | 2.62292858 |
| 139 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.61872324 |
| 140 | cullin deneddylation (GO:0010388) | 2.61355919 |
| 141 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.60910057 |
| 142 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.59862048 |
| 143 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.59517339 |
| 144 | postsynaptic membrane organization (GO:0001941) | 2.58756848 |
| 145 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.58498739 |
| 146 | intracellular pH reduction (GO:0051452) | 2.58421899 |
| 147 | kinetochore organization (GO:0051383) | 2.58324056 |
| 148 | positive regulation of mast cell degranulation (GO:0043306) | 2.57543190 |
| 149 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.57543190 |
| 150 | histone exchange (GO:0043486) | 2.56956481 |
| 151 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.53871860 |
| 152 | cytochrome complex assembly (GO:0017004) | 2.53531189 |
| 153 | positive regulation of mitochondrial fission (GO:0090141) | 2.52079069 |
| 154 | protein K11-linked ubiquitination (GO:0070979) | 2.51753330 |
| 155 | rRNA modification (GO:0000154) | 2.49623955 |
| 156 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.49523044 |
| 157 | nonmotile primary cilium assembly (GO:0035058) | 2.49199017 |
| 158 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.47898539 |
| 159 | purine nucleobase biosynthetic process (GO:0009113) | 2.46804508 |
| 160 | establishment of integrated proviral latency (GO:0075713) | 2.46575275 |
| 161 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.45589927 |
| 162 | base-excision repair, AP site formation (GO:0006285) | 2.44714057 |
| 163 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.44206585 |
| 164 | ubiquinone metabolic process (GO:0006743) | 2.44021861 |
| 165 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.42835150 |
| 166 | ATP synthesis coupled proton transport (GO:0015986) | 2.42835150 |
| 167 | spliceosomal snRNP assembly (GO:0000387) | 2.42650709 |
| 168 | establishment of viral latency (GO:0019043) | 2.42228130 |
| 169 | transcription from mitochondrial promoter (GO:0006390) | 2.41672802 |
| 170 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.41609078 |
| 171 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.41609078 |
| 172 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.39481677 |
| 173 | DNA replication-independent nucleosome organization (GO:0034724) | 2.39481677 |
| 174 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.38691446 |
| 175 | negative regulation of ligase activity (GO:0051352) | 2.38323461 |
| 176 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.38323461 |
| 177 | positive regulation of mast cell activation (GO:0033005) | 2.38276954 |
| 178 | negative regulation of mast cell activation (GO:0033004) | 2.37992107 |
| 179 | protein targeting to mitochondrion (GO:0006626) | 2.37832393 |
| 180 | ubiquinone biosynthetic process (GO:0006744) | 2.37750161 |
| 181 | male meiosis I (GO:0007141) | 2.37630215 |
| 182 | protein localization to mitochondrion (GO:0070585) | 2.37370729 |
| 183 | Sertoli cell development (GO:0060009) | 2.37367762 |
| 184 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.36863923 |
| 185 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.36294991 |
| 186 | histone mRNA metabolic process (GO:0008334) | 2.35297608 |
| 187 | mitochondrial RNA metabolic process (GO:0000959) | 2.34991824 |
| 188 | prenylation (GO:0097354) | 2.34736356 |
| 189 | protein prenylation (GO:0018342) | 2.34736356 |
| 190 | anterograde axon cargo transport (GO:0008089) | 2.32540167 |
| 191 | establishment of protein localization to mitochondrion (GO:0072655) | 2.31604655 |
| 192 | deoxyribose phosphate catabolic process (GO:0046386) | 2.31551043 |
| 193 | cell wall macromolecule metabolic process (GO:0044036) | 2.31411213 |
| 194 | single strand break repair (GO:0000012) | 2.31144667 |
| 195 | spindle checkpoint (GO:0031577) | 2.30886463 |
| 196 | protein deneddylation (GO:0000338) | 2.30250764 |
| 197 | regulation of cilium movement (GO:0003352) | 2.30079908 |
| 198 | Golgi transport vesicle coating (GO:0048200) | 10.9872455 |
| 199 | COPI coating of Golgi vesicle (GO:0048205) | 10.9872455 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 6.18057464 |
| 2 | GATA1_22025678_ChIP-Seq_K562_Human | 4.71863582 |
| 3 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 4.07866819 |
| 4 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 3.66973345 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.57806204 |
| 6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.90936872 |
| 7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.85906351 |
| 8 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.81622135 |
| 9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.77153633 |
| 10 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.76554368 |
| 11 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.62814781 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.51008881 |
| 13 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.49324455 |
| 14 | TFEB_21752829_ChIP-Seq_HELA_Human | 2.41966180 |
| 15 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.38972737 |
| 16 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.38613979 |
| 17 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.34495212 |
| 18 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.32454098 |
| 19 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.21400797 |
| 20 | MYC_18940864_ChIP-ChIP_HL60_Human | 2.19989590 |
| 21 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.19509810 |
| 22 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14606991 |
| 23 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.14153553 |
| 24 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14043686 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.11574275 |
| 26 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.09118450 |
| 27 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 2.01760652 |
| 28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.00284720 |
| 29 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.00098363 |
| 30 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97537098 |
| 31 | EWS_26573619_Chip-Seq_HEK293_Human | 1.94242663 |
| 32 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.93863294 |
| 33 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91610025 |
| 34 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.91576187 |
| 35 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.91537695 |
| 36 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.90832884 |
| 37 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.88371173 |
| 38 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.86971667 |
| 39 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.85210743 |
| 40 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.83670468 |
| 41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.79693832 |
| 42 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.79322070 |
| 43 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.79160293 |
| 44 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.77307108 |
| 45 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.75950530 |
| 46 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.75938106 |
| 47 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.72380347 |
| 48 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.69921763 |
| 49 | MYC_22102868_ChIP-Seq_BL_Human | 1.69591435 |
| 50 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.69148535 |
| 51 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.68838110 |
| 52 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.66618597 |
| 53 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.61399249 |
| 54 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.59595739 |
| 55 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.58421955 |
| 56 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.57225804 |
| 57 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.54470891 |
| 58 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.48536472 |
| 59 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.47716616 |
| 60 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.47338631 |
| 61 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.47108343 |
| 62 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.46934632 |
| 63 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.46396903 |
| 64 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44394762 |
| 65 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.44015279 |
| 66 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.43080492 |
| 67 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.41933976 |
| 68 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.41918587 |
| 69 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.41707387 |
| 70 | MYB_26560356_Chip-Seq_TH2_Human | 1.41543972 |
| 71 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.39717142 |
| 72 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.39366198 |
| 73 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.37165336 |
| 74 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.36436766 |
| 75 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.34637687 |
| 76 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.34455330 |
| 77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.34153875 |
| 78 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.32089456 |
| 79 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.32085997 |
| 80 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.32084775 |
| 81 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.29031766 |
| 82 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.28893284 |
| 83 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.28439907 |
| 84 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.26794081 |
| 85 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.26625602 |
| 86 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.25573369 |
| 87 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.24618716 |
| 88 | FUS_26573619_Chip-Seq_HEK293_Human | 1.24616066 |
| 89 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.23145644 |
| 90 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.19973524 |
| 91 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.18362626 |
| 92 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.17355061 |
| 93 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.17036218 |
| 94 | VDR_22108803_ChIP-Seq_LS180_Human | 1.17004588 |
| 95 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.16857322 |
| 96 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.16409535 |
| 97 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15609833 |
| 98 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.15364931 |
| 99 | GATA3_26560356_Chip-Seq_TH2_Human | 1.14650947 |
| 100 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.14548745 |
| 101 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.13772311 |
| 102 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.09842117 |
| 103 | P300_19829295_ChIP-Seq_ESCs_Human | 1.09463910 |
| 104 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.08793541 |
| 105 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.08292846 |
| 106 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.08238643 |
| 107 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.07429089 |
| 108 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.06953250 |
| 109 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.06665406 |
| 110 | MYB_26560356_Chip-Seq_TH1_Human | 1.03764302 |
| 111 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.03749747 |
| 112 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.02900972 |
| 113 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.02877713 |
| 114 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.02000043 |
| 115 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.01959613 |
| 116 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.01622982 |
| 117 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01137199 |
| 118 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.00888947 |
| 119 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.00622344 |
| 120 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.00496630 |
| 121 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.00316517 |
| 122 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.00023764 |
| 123 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.99396876 |
| 124 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.99236674 |
| 125 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.98493530 |
| 126 | UTX_26944678_Chip-Seq_JUKART_Human | 0.98344770 |
| 127 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.98020098 |
| 128 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97385262 |
| 129 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.96309665 |
| 130 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.95517978 |
| 131 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.94199742 |
| 132 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93691514 |
| 133 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.93493429 |
| 134 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.93353268 |
| 135 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.93218076 |
| 136 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.92451824 |
| 137 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.92172825 |
| 138 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.91758848 |
| 139 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.90220395 |
| 140 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.90090661 |
| 141 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.89937786 |
| 142 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.89855888 |
| 143 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.89855888 |
| 144 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89752299 |
| 145 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.89717142 |
| 146 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.88662102 |
| 147 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.87572484 |
| 148 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.87517604 |
| 149 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.86565998 |
| 150 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.86508662 |
| 151 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.83150527 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002877_abnormal_melanocyte_morpholog | 4.96350088 |
| 2 | MP0003183_abnormal_peptide_metabolism | 4.39280666 |
| 3 | MP0002693_abnormal_pancreas_physiology | 4.17500316 |
| 4 | MP0003136_yellow_coat_color | 3.89055460 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.86620603 |
| 6 | MP0003283_abnormal_digestive_organ | 3.60769109 |
| 7 | MP0001944_abnormal_pancreas_morphology | 3.57084766 |
| 8 | MP0004043_abnormal_pH_regulation | 3.55001836 |
| 9 | MP0010386_abnormal_urinary_bladder | 3.50059569 |
| 10 | MP0008058_abnormal_DNA_repair | 3.19428844 |
| 11 | MP0003172_abnormal_lysosome_physiology | 3.18912623 |
| 12 | MP0009780_abnormal_chondrocyte_physiolo | 3.17676041 |
| 13 | MP0000372_irregular_coat_pigmentation | 2.98898298 |
| 14 | MP0005379_endocrine/exocrine_gland_phen | 2.88272377 |
| 15 | MP0002653_abnormal_ependyma_morphology | 2.85340972 |
| 16 | MP0003195_calcinosis | 2.81382912 |
| 17 | MP0005220_abnormal_exocrine_pancreas | 2.73631986 |
| 18 | MP0002909_abnormal_adrenal_gland | 2.73611717 |
| 19 | MP0000013_abnormal_adipose_tissue | 2.66788820 |
| 20 | MP0000678_abnormal_parathyroid_gland | 2.52422176 |
| 21 | MP0001529_abnormal_vocalization | 2.40512723 |
| 22 | MP0001986_abnormal_taste_sensitivity | 2.35167430 |
| 23 | MP0003880_abnormal_central_pattern | 2.34415279 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.27434808 |
| 25 | MP0005171_absent_coat_pigmentation | 2.07108627 |
| 26 | MP0002078_abnormal_glucose_homeostasis | 2.01040273 |
| 27 | MP0002736_abnormal_nociception_after | 1.98620672 |
| 28 | MP0002638_abnormal_pupillary_reflex | 1.90048148 |
| 29 | MP0000778_abnormal_nervous_system | 1.88615922 |
| 30 | MP0005257_abnormal_intraocular_pressure | 1.88474665 |
| 31 | MP0002928_abnormal_bile_duct | 1.87891915 |
| 32 | MP0010094_abnormal_chromosome_stability | 1.87626884 |
| 33 | MP0006292_abnormal_olfactory_placode | 1.84498874 |
| 34 | MP0006054_spinal_hemorrhage | 1.83769054 |
| 35 | MP0003121_genomic_imprinting | 1.82969792 |
| 36 | MP0005310_abnormal_salivary_gland | 1.77391129 |
| 37 | MP0005646_abnormal_pituitary_gland | 1.75956019 |
| 38 | MP0004742_abnormal_vestibular_system | 1.71442614 |
| 39 | MP0004142_abnormal_muscle_tone | 1.70351862 |
| 40 | MP0006072_abnormal_retinal_apoptosis | 1.65066433 |
| 41 | MP0006276_abnormal_autonomic_nervous | 1.64774246 |
| 42 | MP0002735_abnormal_chemical_nociception | 1.58219785 |
| 43 | MP0005671_abnormal_response_to | 1.55581734 |
| 44 | MP0001835_abnormal_antigen_presentation | 1.52846713 |
| 45 | MP0001968_abnormal_touch/_nociception | 1.51068775 |
| 46 | MP0001984_abnormal_olfaction | 1.47158615 |
| 47 | MP0000647_abnormal_sebaceous_gland | 1.45819062 |
| 48 | MP0000003_abnormal_adipose_tissue | 1.41096942 |
| 49 | MP0006035_abnormal_mitochondrial_morpho | 1.40520595 |
| 50 | MP0003866_abnormal_defecation | 1.37725263 |
| 51 | MP0003077_abnormal_cell_cycle | 1.37537898 |
| 52 | MP0005645_abnormal_hypothalamus_physiol | 1.36082668 |
| 53 | MP0003122_maternal_imprinting | 1.35646909 |
| 54 | MP0004133_heterotaxia | 1.33242912 |
| 55 | MP0004957_abnormal_blastocyst_morpholog | 1.31525205 |
| 56 | MP0008932_abnormal_embryonic_tissue | 1.28827701 |
| 57 | MP0002102_abnormal_ear_morphology | 1.27891693 |
| 58 | MP0008961_abnormal_basal_metabolism | 1.27455697 |
| 59 | MP0005000_abnormal_immune_tolerance | 1.25649812 |
| 60 | MP0005499_abnormal_olfactory_system | 1.25351124 |
| 61 | MP0005394_taste/olfaction_phenotype | 1.25351124 |
| 62 | MP0008877_abnormal_DNA_methylation | 1.24888809 |
| 63 | MP0009643_abnormal_urine_homeostasis | 1.23299169 |
| 64 | MP0000015_abnormal_ear_pigmentation | 1.22867916 |
| 65 | MP0001293_anophthalmia | 1.21758372 |
| 66 | MP0008789_abnormal_olfactory_epithelium | 1.20586117 |
| 67 | MP0004264_abnormal_extraembryonic_tissu | 1.20301943 |
| 68 | MP0008007_abnormal_cellular_replicative | 1.19975529 |
| 69 | MP0001545_abnormal_hematopoietic_system | 1.19701647 |
| 70 | MP0005397_hematopoietic_system_phenotyp | 1.19701647 |
| 71 | MP0000343_altered_response_to | 1.19464036 |
| 72 | MP0003718_maternal_effect | 1.17725006 |
| 73 | MP0003111_abnormal_nucleus_morphology | 1.16604547 |
| 74 | MP0003786_premature_aging | 1.15710076 |
| 75 | MP0001756_abnormal_urination | 1.15127012 |
| 76 | MP0003953_abnormal_hormone_level | 1.14675288 |
| 77 | MP0005084_abnormal_gallbladder_morpholo | 1.14557221 |
| 78 | MP0003186_abnormal_redox_activity | 1.13913785 |
| 79 | MP0002896_abnormal_bone_mineralization | 1.12538198 |
| 80 | MP0001765_abnormal_ion_homeostasis | 1.11319836 |
| 81 | MP0009046_muscle_twitch | 1.07780182 |
| 82 | MP0009764_decreased_sensitivity_to | 1.07635301 |
| 83 | MP0001324_abnormal_eye_pigmentation | 1.06162542 |
| 84 | MP0005075_abnormal_melanosome_morpholog | 1.05041868 |
| 85 | MP0005174_abnormal_tail_pigmentation | 1.04931900 |
| 86 | MP0005551_abnormal_eye_electrophysiolog | 1.03892852 |
| 87 | MP0002837_dystrophic_cardiac_calcinosis | 1.02893842 |
| 88 | MP0001186_pigmentation_phenotype | 1.02770538 |
| 89 | MP0006036_abnormal_mitochondrial_physio | 1.02449633 |
| 90 | MP0000631_abnormal_neuroendocrine_gland | 1.02293716 |
| 91 | MP0001929_abnormal_gametogenesis | 1.01445181 |
| 92 | MP0000681_abnormal_thyroid_gland | 1.01133899 |
| 93 | MP0002229_neurodegeneration | 1.00691838 |
| 94 | MP0003890_abnormal_embryonic-extraembry | 0.98793925 |
| 95 | MP0005387_immune_system_phenotype | 0.98712641 |
| 96 | MP0001790_abnormal_immune_system | 0.98712641 |
| 97 | MP0003795_abnormal_bone_structure | 0.98419754 |
| 98 | MP0004811_abnormal_neuron_physiology | 0.97758760 |
| 99 | MP0002419_abnormal_innate_immunity | 0.97006805 |
| 100 | MP0000920_abnormal_myelination | 0.96738113 |
| 101 | MP0002067_abnormal_sensory_capabilities | 0.95782177 |
| 102 | MP0000462_abnormal_digestive_system | 0.95485998 |
| 103 | MP0005636_abnormal_mineral_homeostasis | 0.94518278 |
| 104 | MP0002723_abnormal_immune_serum | 0.93642197 |
| 105 | MP0001486_abnormal_startle_reflex | 0.92636423 |
| 106 | MP0005464_abnormal_platelet_physiology | 0.92246276 |
| 107 | MP0005410_abnormal_fertilization | 0.92237144 |
| 108 | MP0002272_abnormal_nervous_system | 0.92168391 |
| 109 | MP0002210_abnormal_sex_determination | 0.91987863 |
| 110 | MP0000371_diluted_coat_color | 0.91630947 |
| 111 | MP0005367_renal/urinary_system_phenotyp | 0.91505393 |
| 112 | MP0000516_abnormal_urinary_system | 0.91505393 |
| 113 | MP0002420_abnormal_adaptive_immunity | 0.89630787 |
| 114 | MP0001819_abnormal_immune_cell | 0.89253198 |
| 115 | MP0001764_abnormal_homeostasis | 0.88997182 |
| 116 | MP0005408_hypopigmentation | 0.88834052 |
| 117 | MP0002064_seizures | 0.88487522 |
| 118 | MP0009765_abnormal_xenobiotic_induced | 0.87778903 |
| 119 | MP0009278_abnormal_bone_marrow | 0.87640540 |
| 120 | MP0005195_abnormal_posterior_eye | 0.87343326 |
| 121 | MP0002148_abnormal_hypersensitivity_rea | 0.87285891 |
| 122 | MP0002452_abnormal_antigen_presenting | 0.87114618 |
| 123 | MP0001853_heart_inflammation | 0.86939569 |
| 124 | MP0000613_abnormal_salivary_gland | 0.85772035 |
| 125 | MP0000955_abnormal_spinal_cord | 0.84684952 |
| 126 | MP0001970_abnormal_pain_threshold | 0.83345882 |
| 127 | MP0003787_abnormal_imprinting | 0.82818645 |
| 128 | MP0002882_abnormal_neuron_morphology | 0.82632446 |
| 129 | MP0002752_abnormal_somatic_nervous | 0.82490013 |
| 130 | MP0009745_abnormal_behavioral_response | 0.82177060 |
| 131 | MP0001905_abnormal_dopamine_level | 0.81040467 |
| 132 | MP0003436_decreased_susceptibility_to | 0.80648041 |
| 133 | MP0001485_abnormal_pinna_reflex | 0.80236758 |
| 134 | MP0003698_abnormal_male_reproductive | 0.79698848 |
| 135 | MP0002152_abnormal_brain_morphology | 0.79556088 |
| 136 | MP0003693_abnormal_embryo_hatching | 0.79188395 |
| 137 | MP0003959_abnormal_lean_body | 0.79020502 |
| 138 | MP0003763_abnormal_thymus_physiology | 0.78953848 |
| 139 | MP0005391_vision/eye_phenotype | 0.78411691 |
| 140 | MP0006082_CNS_inflammation | 0.78094359 |
| 141 | MP0001845_abnormal_inflammatory_respons | 0.77756008 |
| 142 | MP0004885_abnormal_endolymph | 0.75384638 |
| 143 | MP0002398_abnormal_bone_marrow | 0.75193703 |
| 144 | MP0002163_abnormal_gland_morphology | 0.74908885 |
| 145 | MP0000569_abnormal_digit_pigmentation | 0.73957579 |
| 146 | MP0002938_white_spotting | 0.73359668 |
| 147 | MP0000639_abnormal_adrenal_gland | 0.72993886 |
| 148 | MP0000716_abnormal_immune_system | 0.72562903 |
| 149 | MP0002090_abnormal_vision | 0.72473268 |
| 150 | MP0002095_abnormal_skin_pigmentation | 0.72041981 |
| 151 | MP0001800_abnormal_humoral_immune | 0.70053579 |
| 152 | MP0009333_abnormal_splenocyte_physiolog | 0.70006807 |
| 153 | MP0000358_abnormal_cell_content/ | 0.69643374 |
| 154 | MP0002138_abnormal_hepatobiliary_system | 0.69583030 |
| 155 | MP0002396_abnormal_hematopoietic_system | 0.69404159 |
| 156 | MP0000465_gastrointestinal_hemorrhage | 0.68858720 |
| 157 | MP0009672_abnormal_birth_weight | 0.68758512 |
| 158 | MP0000538_abnormal_urinary_bladder | 0.67304885 |
| 159 | MP0001661_extended_life_span | 0.67018029 |
| 160 | MP0001727_abnormal_embryo_implantation | 0.66928548 |
| 161 | MP0003943_abnormal_hepatobiliary_system | 0.66520047 |
| 162 | MP0005253_abnormal_eye_physiology | 0.66257927 |
| 163 | MP0001270_distended_abdomen | 0.66035303 |
| 164 | MP0002075_abnormal_coat/hair_pigmentati | 0.64848817 |
| 165 | MP0003303_peritoneal_inflammation | 0.63226809 |
| 166 | MP0002751_abnormal_autonomic_nervous | 0.62331581 |
| 167 | MP0002429_abnormal_blood_cell | 0.62159792 |
| 168 | MP0001533_abnormal_skeleton_physiology | 0.62108613 |
| 169 | MP0005025_abnormal_response_to | 0.61648008 |
| 170 | MP0003634_abnormal_glial_cell | 0.60601607 |
| 171 | MP0009642_abnormal_blood_homeostasis | 0.59839813 |
| 172 | MP0000685_abnormal_immune_system | 0.59390861 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 6.10215838 |
| 2 | Hypoglycemic seizures (HP:0002173) | 6.06557731 |
| 3 | Symptomatic seizures (HP:0011145) | 5.49762213 |
| 4 | Dysostosis multiplex (HP:0000943) | 5.24341473 |
| 5 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.93382457 |
| 6 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.84119583 |
| 7 | Mucopolysacchariduria (HP:0008155) | 4.84119583 |
| 8 | Hypoglycemic coma (HP:0001325) | 4.74797210 |
| 9 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.47099635 |
| 10 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.47099635 |
| 11 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.47099635 |
| 12 | Increased cerebral lipofuscin (HP:0011813) | 4.12084985 |
| 13 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.07513798 |
| 14 | Vacuolated lymphocytes (HP:0001922) | 4.02502396 |
| 15 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.97607699 |
| 16 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.97607699 |
| 17 | Abnormality of glycolipid metabolism (HP:0010969) | 3.97607699 |
| 18 | Late onset (HP:0003584) | 3.67680166 |
| 19 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.60229834 |
| 20 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.60229834 |
| 21 | Large for gestational age (HP:0001520) | 3.55325238 |
| 22 | Generalized aminoaciduria (HP:0002909) | 3.41783208 |
| 23 | 3-Methylglutaconic aciduria (HP:0003535) | 3.40292525 |
| 24 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.30507662 |
| 25 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.28140843 |
| 26 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.24257500 |
| 27 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.24257500 |
| 28 | Abnormal protein glycosylation (HP:0012346) | 3.24257500 |
| 29 | Abnormal glycosylation (HP:0012345) | 3.24257500 |
| 30 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.17982770 |
| 31 | Hyperglycemia (HP:0003074) | 3.13952462 |
| 32 | Progressive neurologic deterioration (HP:0002344) | 3.11453036 |
| 33 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.07570397 |
| 34 | Abnormal pancreas size (HP:0012094) | 3.03406001 |
| 35 | Type I transferrin isoform profile (HP:0003642) | 3.02918707 |
| 36 | Decreased circulating renin level (HP:0003351) | 2.97173257 |
| 37 | Molar tooth sign on MRI (HP:0002419) | 2.82946921 |
| 38 | Abnormality of midbrain morphology (HP:0002418) | 2.82946921 |
| 39 | Disinhibition (HP:0000734) | 2.81438586 |
| 40 | Ketoacidosis (HP:0001993) | 2.76591035 |
| 41 | Mutism (HP:0002300) | 2.66078598 |
| 42 | Acute necrotizing encephalopathy (HP:0006965) | 2.61978591 |
| 43 | Volvulus (HP:0002580) | 2.59206909 |
| 44 | Abnormality of the labia minora (HP:0012880) | 2.57469028 |
| 45 | 11 pairs of ribs (HP:0000878) | 2.51955084 |
| 46 | Osteomalacia (HP:0002749) | 2.51808628 |
| 47 | Hypothermia (HP:0002045) | 2.51689389 |
| 48 | Hypokalemia (HP:0002900) | 2.50677322 |
| 49 | Intestinal atresia (HP:0011100) | 2.50581422 |
| 50 | Retinal atrophy (HP:0001105) | 2.48920245 |
| 51 | Mitochondrial inheritance (HP:0001427) | 2.47773686 |
| 52 | Retinal dysplasia (HP:0007973) | 2.45614977 |
| 53 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.45433182 |
| 54 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.45433182 |
| 55 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.45289497 |
| 56 | Hypoplasia of the fovea (HP:0007750) | 2.45289497 |
| 57 | Medial flaring of the eyebrow (HP:0010747) | 2.45171694 |
| 58 | B lymphocytopenia (HP:0010976) | 2.45121749 |
| 59 | Lipid accumulation in hepatocytes (HP:0006561) | 2.44620847 |
| 60 | Acute encephalopathy (HP:0006846) | 2.43070031 |
| 61 | Increased CSF lactate (HP:0002490) | 2.41569369 |
| 62 | Thoracolumbar scoliosis (HP:0002944) | 2.39596226 |
| 63 | Increased hepatocellular lipid droplets (HP:0006565) | 2.38306935 |
| 64 | Agitation (HP:0000713) | 2.36242489 |
| 65 | Abnormality of the intrinsic pathway (HP:0010989) | 2.35304029 |
| 66 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.35229312 |
| 67 | Prominent metopic ridge (HP:0005487) | 2.34684220 |
| 68 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.33309815 |
| 69 | Renal Fanconi syndrome (HP:0001994) | 2.31084175 |
| 70 | Progressive macrocephaly (HP:0004481) | 2.29759233 |
| 71 | Panhypogammaglobulinemia (HP:0003139) | 2.29507474 |
| 72 | Tubulointerstitial nephritis (HP:0001970) | 2.28302142 |
| 73 | True hermaphroditism (HP:0010459) | 2.28156676 |
| 74 | Hyperglycinemia (HP:0002154) | 2.27490299 |
| 75 | Inappropriate behavior (HP:0000719) | 2.24461387 |
| 76 | Polyphagia (HP:0002591) | 2.21871923 |
| 77 | Abnormality of the fovea (HP:0000493) | 2.21519378 |
| 78 | Insulin resistance (HP:0000855) | 2.19120297 |
| 79 | Nephronophthisis (HP:0000090) | 2.16820038 |
| 80 | Albinism (HP:0001022) | 2.16172650 |
| 81 | Hepatocellular necrosis (HP:0001404) | 2.15947307 |
| 82 | Conjugated hyperbilirubinemia (HP:0002908) | 2.15774220 |
| 83 | Papilledema (HP:0001085) | 2.15535740 |
| 84 | Oligodactyly (hands) (HP:0001180) | 2.14978344 |
| 85 | Abnormality of the corticospinal tract (HP:0002492) | 2.14262453 |
| 86 | Type II lissencephaly (HP:0007260) | 2.13672980 |
| 87 | Increased serum pyruvate (HP:0003542) | 2.12297397 |
| 88 | Hyperparathyroidism (HP:0000843) | 2.10674753 |
| 89 | Petechiae (HP:0000967) | 2.08961744 |
| 90 | Cortical dysplasia (HP:0002539) | 2.08389462 |
| 91 | Nephrogenic diabetes insipidus (HP:0009806) | 2.08012027 |
| 92 | Dysautonomia (HP:0002459) | 2.07990269 |
| 93 | Combined immunodeficiency (HP:0005387) | 2.07864779 |
| 94 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.06597194 |
| 95 | Severe short stature (HP:0003510) | 2.04849938 |
| 96 | Cerebral hypomyelination (HP:0006808) | 2.04837105 |
| 97 | Lissencephaly (HP:0001339) | 2.04352028 |
| 98 | Abnormality of the anterior horn cell (HP:0006802) | 2.03142501 |
| 99 | Degeneration of anterior horn cells (HP:0002398) | 2.03142501 |
| 100 | Hypoplasia of the thymus (HP:0000778) | 2.02746837 |
| 101 | Menstrual irregularities (HP:0000858) | 2.02691321 |
| 102 | Abnormality of the metopic suture (HP:0005556) | 2.00486922 |
| 103 | Limb hypertonia (HP:0002509) | 2.00197783 |
| 104 | Cerebellar dysplasia (HP:0007033) | 1.94357296 |
| 105 | Broad face (HP:0000283) | 1.94130786 |
| 106 | Pancreatic fibrosis (HP:0100732) | 1.93482893 |
| 107 | Increased serum lactate (HP:0002151) | 1.92619331 |
| 108 | Patchy hypopigmentation of hair (HP:0011365) | 1.92326262 |
| 109 | Exocrine pancreatic insufficiency (HP:0001738) | 1.91489800 |
| 110 | Lactic acidosis (HP:0003128) | 1.91396811 |
| 111 | Abnormality of B cell number (HP:0010975) | 1.91177293 |
| 112 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.90756359 |
| 113 | Abnormality of alanine metabolism (HP:0010916) | 1.90756359 |
| 114 | Hyperalaninemia (HP:0003348) | 1.90756359 |
| 115 | Cortical visual impairment (HP:0100704) | 1.89922190 |
| 116 | White forelock (HP:0002211) | 1.88975110 |
| 117 | Concave nail (HP:0001598) | 1.86960069 |
| 118 | Hepatic necrosis (HP:0002605) | 1.86751943 |
| 119 | Drooling (HP:0002307) | 1.85739890 |
| 120 | Cardiomegaly (HP:0001640) | 1.85036996 |
| 121 | CNS hypomyelination (HP:0003429) | 1.84778375 |
| 122 | Oculomotor apraxia (HP:0000657) | 1.84629253 |
| 123 | Abnormal biliary tract physiology (HP:0012439) | 1.83896902 |
| 124 | Bile duct proliferation (HP:0001408) | 1.83896902 |
| 125 | Widely spaced teeth (HP:0000687) | 1.83680398 |
| 126 | Chronic bronchitis (HP:0004469) | 1.83056992 |
| 127 | Microvesicular hepatic steatosis (HP:0001414) | 1.82915008 |
| 128 | Gait imbalance (HP:0002141) | 1.82573169 |
| 129 | Aplastic anemia (HP:0001915) | 1.82544161 |
| 130 | Disproportionate short-trunk short stature (HP:0003521) | 1.79210191 |
| 131 | Severe combined immunodeficiency (HP:0004430) | 1.78732673 |
| 132 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.78686196 |
| 133 | Congenital primary aphakia (HP:0007707) | 1.78508429 |
| 134 | Cystic liver disease (HP:0006706) | 1.78001385 |
| 135 | Decreased subcutaneous fat (HP:0001002) | 1.77606533 |
| 136 | Abnormality of glycolysis (HP:0004366) | 1.77441690 |
| 137 | Asymmetric septal hypertrophy (HP:0001670) | 1.76805783 |
| 138 | Spinal muscular atrophy (HP:0007269) | 1.75797835 |
| 139 | Abnormality of renin-angiotensin system (HP:0000847) | 1.75366316 |
| 140 | Abdominal distention (HP:0003270) | 1.75356522 |
| 141 | Septo-optic dysplasia (HP:0100842) | 1.74737672 |
| 142 | Abnormality of the renal medulla (HP:0100957) | 1.74265584 |
| 143 | Agnosia (HP:0010524) | 1.73161310 |
| 144 | Recurrent abscess formation (HP:0002722) | 1.73069720 |
| 145 | Constricted visual fields (HP:0001133) | 1.72969646 |
| 146 | Abolished electroretinogram (ERG) (HP:0000550) | 1.72564060 |
| 147 | Pancreatic cysts (HP:0001737) | 1.71768489 |
| 148 | Abnormality of potassium homeostasis (HP:0011042) | 1.71499262 |
| 149 | Hypophosphatemia (HP:0002148) | 1.71382162 |
| 150 | Irregular vertebral endplates (HP:0003301) | 1.71332582 |
| 151 | Birth length less than 3rd percentile (HP:0003561) | 1.70446728 |
| 152 | Unilateral renal agenesis (HP:0000122) | 1.69429151 |
| 153 | Missing ribs (HP:0000921) | 1.68226101 |
| 154 | Reduced antithrombin III activity (HP:0001976) | 1.67231812 |
| 155 | Cerebral edema (HP:0002181) | 1.67001974 |
| 156 | Hyperphosphaturia (HP:0003109) | 1.65862426 |
| 157 | CNS demyelination (HP:0007305) | 1.65395700 |
| 158 | Excessive salivation (HP:0003781) | 1.65392294 |
| 159 | Spondylolisthesis (HP:0003302) | 1.65314711 |
| 160 | Bifid tongue (HP:0010297) | 1.64430187 |
| 161 | Optic nerve hypoplasia (HP:0000609) | 1.64166259 |
| 162 | Aganglionic megacolon (HP:0002251) | 1.62591390 |
| 163 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.62507221 |
| 164 | Abnormality of T cell physiology (HP:0011840) | 1.62391611 |
| 165 | Optic disc pallor (HP:0000543) | 1.62184123 |
| 166 | Amyotrophic lateral sclerosis (HP:0007354) | 1.62012858 |
| 167 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.61667002 |
| 168 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.61505217 |
| 169 | Oligodactyly (HP:0012165) | 1.60990597 |
| 170 | Glycosuria (HP:0003076) | 1.60663124 |
| 171 | Abnormality of urine glucose concentration (HP:0011016) | 1.60663124 |
| 172 | Elevated alkaline phosphatase (HP:0003155) | 1.59051958 |
| 173 | Pheochromocytoma (HP:0002666) | 1.58997794 |
| 174 | Hypoplastic pelvis (HP:0008839) | 1.58647918 |
| 175 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.57825953 |
| 176 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.57642845 |
| 177 | Hypercortisolism (HP:0001578) | 1.56018755 |
| 178 | Neuroendocrine neoplasm (HP:0100634) | 1.55912626 |
| 179 | Thrombocytosis (HP:0001894) | 1.55125568 |
| 180 | Poor head control (HP:0002421) | 1.55081012 |
| 181 | IgM deficiency (HP:0002850) | 1.53423154 |
| 182 | Basal ganglia calcification (HP:0002135) | 1.52931247 |
| 183 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.49453315 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PASK | 6.06393255 |
| 2 | INSRR | 6.01761344 |
| 3 | MAPK15 | 3.99633839 |
| 4 | FLT3 | 3.35351558 |
| 5 | PRKD3 | 3.33762293 |
| 6 | MAP4K2 | 3.23922069 |
| 7 | BUB1 | 3.18376537 |
| 8 | TAOK3 | 2.95079254 |
| 9 | HIPK2 | 2.82787301 |
| 10 | SCYL2 | 2.79047719 |
| 11 | PNCK | 2.61857830 |
| 12 | VRK2 | 2.49417924 |
| 13 | ERN1 | 2.47008263 |
| 14 | TRIM28 | 2.45809105 |
| 15 | NME2 | 2.26037591 |
| 16 | IRAK3 | 2.12559538 |
| 17 | CDK19 | 2.09298456 |
| 18 | WEE1 | 2.02874593 |
| 19 | EIF2AK3 | 2.00304286 |
| 20 | PBK | 2.00009400 |
| 21 | STK16 | 1.92125029 |
| 22 | EPHA4 | 1.73637524 |
| 23 | SRPK1 | 1.70166675 |
| 24 | ITK | 1.65334898 |
| 25 | BRD4 | 1.62405524 |
| 26 | IRAK4 | 1.56732180 |
| 27 | KIT | 1.51414754 |
| 28 | CSNK1G2 | 1.49849971 |
| 29 | ZAK | 1.48452738 |
| 30 | TEC | 1.47544914 |
| 31 | CSNK1G3 | 1.46338902 |
| 32 | CASK | 1.46081073 |
| 33 | BTK | 1.45968501 |
| 34 | ZAP70 | 1.44734516 |
| 35 | VRK1 | 1.43351991 |
| 36 | TESK2 | 1.41596736 |
| 37 | TRIB3 | 1.40564502 |
| 38 | MAP2K7 | 1.38312684 |
| 39 | BRSK2 | 1.36292678 |
| 40 | CDC7 | 1.35990154 |
| 41 | CSNK1G1 | 1.32684655 |
| 42 | CSF1R | 1.31621203 |
| 43 | PLK4 | 1.27381797 |
| 44 | TGFBR2 | 1.26475216 |
| 45 | BCR | 1.23629878 |
| 46 | MST4 | 1.22039421 |
| 47 | WNK3 | 1.21376561 |
| 48 | TNIK | 1.21116887 |
| 49 | MAP3K2 | 1.20434407 |
| 50 | DYRK2 | 1.20148422 |
| 51 | PKN1 | 1.19413811 |
| 52 | PLK2 | 1.18922510 |
| 53 | PTK6 | 1.18272246 |
| 54 | MARK1 | 1.16719967 |
| 55 | UHMK1 | 1.11905098 |
| 56 | WNK4 | 1.11889257 |
| 57 | DYRK1B | 1.11347615 |
| 58 | YES1 | 1.06282584 |
| 59 | CDC42BPA | 1.06240293 |
| 60 | OXSR1 | 1.05110970 |
| 61 | EPHA3 | 1.05079520 |
| 62 | MATK | 1.03938435 |
| 63 | MKNK1 | 1.02165970 |
| 64 | CAMKK2 | 1.00772369 |
| 65 | KSR1 | 1.00318496 |
| 66 | NEK1 | 0.99713142 |
| 67 | PLK3 | 0.98350357 |
| 68 | IRAK1 | 0.97640840 |
| 69 | STK39 | 0.96038636 |
| 70 | TBK1 | 0.95759348 |
| 71 | SYK | 0.94494207 |
| 72 | MINK1 | 0.93703835 |
| 73 | JAK3 | 0.93385492 |
| 74 | NTRK1 | 0.92361247 |
| 75 | CDK3 | 0.90591313 |
| 76 | MAP3K10 | 0.89927695 |
| 77 | PLK1 | 0.89871573 |
| 78 | PRKCH | 0.89092536 |
| 79 | PDGFRA | 0.88540008 |
| 80 | DYRK3 | 0.87892898 |
| 81 | PIM2 | 0.87472259 |
| 82 | MAP4K1 | 0.86251176 |
| 83 | BMPR1B | 0.75870505 |
| 84 | NTRK2 | 0.72693354 |
| 85 | PTK2 | 0.72637906 |
| 86 | TYK2 | 0.72285975 |
| 87 | ADRBK2 | 0.71005516 |
| 88 | RPS6KA2 | 0.70280769 |
| 89 | LYN | 0.68832331 |
| 90 | TTK | 0.68138996 |
| 91 | BRSK1 | 0.68050214 |
| 92 | CHEK2 | 0.67921828 |
| 93 | MAP3K1 | 0.67290119 |
| 94 | MAP3K4 | 0.66390908 |
| 95 | PIK3CG | 0.65699605 |
| 96 | PRKCG | 0.65238238 |
| 97 | EPHB2 | 0.64178991 |
| 98 | SIK3 | 0.63404134 |
| 99 | ACVR1B | 0.62070726 |
| 100 | FGFR4 | 0.61999171 |
| 101 | FRK | 0.61830227 |
| 102 | NME1 | 0.61188821 |
| 103 | ERBB3 | 0.61013930 |
| 104 | CSNK2A1 | 0.60429673 |
| 105 | FGR | 0.59410988 |
| 106 | PRKD2 | 0.58567761 |
| 107 | TSSK6 | 0.57885857 |
| 108 | CHUK | 0.57846190 |
| 109 | JAK1 | 0.56244835 |
| 110 | AURKA | 0.56189781 |
| 111 | RPS6KA4 | 0.55618483 |
| 112 | JAK2 | 0.54917741 |
| 113 | RAF1 | 0.53696192 |
| 114 | ABL2 | 0.51702337 |
| 115 | AURKB | 0.50578130 |
| 116 | PDK2 | 0.49421195 |
| 117 | LCK | 0.47850419 |
| 118 | MKNK2 | 0.46607392 |
| 119 | EIF2AK2 | 0.46461141 |
| 120 | BRAF | 0.46446459 |
| 121 | PAK3 | 0.45980712 |
| 122 | CSNK1A1L | 0.45965501 |
| 123 | TGFBR1 | 0.43411417 |
| 124 | CSK | 0.43200874 |
| 125 | ATM | 0.42487643 |
| 126 | CDK14 | 0.42379582 |
| 127 | BCKDK | 0.42085554 |
| 128 | CLK1 | 0.41822027 |
| 129 | NUAK1 | 0.41505485 |
| 130 | MAP2K2 | 0.41336444 |
| 131 | PIM1 | 0.40395396 |
| 132 | MARK3 | 0.39028578 |
| 133 | CDK18 | 0.37809259 |
| 134 | STK38L | 0.37590335 |
| 135 | CSNK2A2 | 0.37536471 |
| 136 | MET | 0.35755555 |
| 137 | ATR | 0.35644383 |
| 138 | CDK8 | 0.35170035 |
| 139 | CHEK1 | 0.35005430 |
| 140 | CDK11A | 0.34494340 |
| 141 | EIF2AK1 | 0.34417777 |
| 142 | STK10 | 0.34199973 |
| 143 | RPS6KA6 | 0.33190786 |
| 144 | PRKCD | 0.32864293 |
| 145 | CDK15 | 0.31848180 |
| 146 | CCNB1 | 0.31503328 |
| 147 | IGF1R | 0.31079152 |
| 148 | MAPK3 | 0.30607685 |
| 149 | MAP3K5 | 0.29960537 |
| 150 | PRKCE | 0.29821910 |
| 151 | GRK7 | 0.28242080 |
| 152 | MAPKAPK2 | 0.27789379 |
| 153 | RPS6KC1 | 0.27303015 |
| 154 | RPS6KL1 | 0.27303015 |
| 155 | NLK | 0.26243996 |
| 156 | RET | 0.25703251 |
| 157 | PRKDC | 0.24193891 |
| 158 | FES | 0.23773467 |
| 159 | AKT1 | 0.23202900 |
| 160 | MAPK13 | 0.21727150 |
| 161 | RPS6KA5 | 0.21570249 |
| 162 | RPS6KB1 | 0.20839134 |
| 163 | TESK1 | 0.20170586 |
| 164 | DYRK1A | 0.19871908 |
| 165 | MAPK14 | 0.19397401 |
| 166 | TLK1 | 0.19055772 |
| 167 | CDK9 | 0.18628843 |
| 168 | NEK9 | 0.17907466 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 7.91574752 |
| 2 | Protein export_Homo sapiens_hsa03060 | 6.15050886 |
| 3 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.10887432 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.02033478 |
| 5 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.98976449 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.92495984 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.88795392 |
| 8 | Lysosome_Homo sapiens_hsa04142 | 2.61333606 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.60565217 |
| 10 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.56956325 |
| 11 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.46363876 |
| 12 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.45657649 |
| 13 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.36776334 |
| 14 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.23252648 |
| 15 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.10447155 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 2.05716754 |
| 17 | Asthma_Homo sapiens_hsa05310 | 2.03817942 |
| 18 | Ribosome_Homo sapiens_hsa03010 | 1.91290921 |
| 19 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.86742422 |
| 20 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.83557310 |
| 21 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.81747664 |
| 22 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.66023851 |
| 23 | Huntingtons disease_Homo sapiens_hsa05016 | 1.62725342 |
| 24 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.61783864 |
| 25 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.53260017 |
| 26 | RNA transport_Homo sapiens_hsa03013 | 1.51765625 |
| 27 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.50480622 |
| 28 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.46994220 |
| 29 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.46766707 |
| 30 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.43765980 |
| 31 | Alzheimers disease_Homo sapiens_hsa05010 | 1.32679556 |
| 32 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.30147436 |
| 33 | Sulfur relay system_Homo sapiens_hsa04122 | 1.18535499 |
| 34 | Legionellosis_Homo sapiens_hsa05134 | 1.15686717 |
| 35 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.15045708 |
| 36 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.14695728 |
| 37 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.14230259 |
| 38 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.11688977 |
| 39 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.07114132 |
| 40 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.04744086 |
| 41 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.03164109 |
| 42 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.00217276 |
| 43 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.99714335 |
| 44 | Allograft rejection_Homo sapiens_hsa05330 | 0.99395388 |
| 45 | Phagosome_Homo sapiens_hsa04145 | 0.98477045 |
| 46 | Cocaine addiction_Homo sapiens_hsa05030 | 0.97834264 |
| 47 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.97442178 |
| 48 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.95474729 |
| 49 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.91573223 |
| 50 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.89590952 |
| 51 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.89316601 |
| 52 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.86611038 |
| 53 | Galactose metabolism_Homo sapiens_hsa00052 | 0.84338891 |
| 54 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.84045469 |
| 55 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.81707827 |
| 56 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.81669691 |
| 57 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.80097467 |
| 58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.79450239 |
| 59 | Salmonella infection_Homo sapiens_hsa05132 | 0.74319638 |
| 60 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.72629457 |
| 61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.72566065 |
| 62 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.70558322 |
| 63 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.69795455 |
| 64 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.69631798 |
| 65 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67726196 |
| 66 | Phototransduction_Homo sapiens_hsa04744 | 0.66885402 |
| 67 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.66642535 |
| 68 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.64372336 |
| 69 | Insulin resistance_Homo sapiens_hsa04931 | 0.63171602 |
| 70 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.62571645 |
| 71 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.61513793 |
| 72 | Nicotine addiction_Homo sapiens_hsa05033 | 0.60088391 |
| 73 | Mismatch repair_Homo sapiens_hsa03430 | 0.59952919 |
| 74 | Alcoholism_Homo sapiens_hsa05034 | 0.59166688 |
| 75 | Leishmaniasis_Homo sapiens_hsa05140 | 0.58535032 |
| 76 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.55770565 |
| 77 | Peroxisome_Homo sapiens_hsa04146 | 0.53896415 |
| 78 | Pertussis_Homo sapiens_hsa05133 | 0.52568591 |
| 79 | DNA replication_Homo sapiens_hsa03030 | 0.52438901 |
| 80 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.51559251 |
| 81 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.51134732 |
| 82 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50895314 |
| 83 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.47960617 |
| 84 | Measles_Homo sapiens_hsa05162 | 0.47527679 |
| 85 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47430387 |
| 86 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.47319048 |
| 87 | Circadian rhythm_Homo sapiens_hsa04710 | 0.46738359 |
| 88 | Tuberculosis_Homo sapiens_hsa05152 | 0.45612210 |
| 89 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.45320898 |
| 90 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.45037335 |
| 91 | Base excision repair_Homo sapiens_hsa03410 | 0.44638393 |
| 92 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.43833621 |
| 93 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.43722840 |
| 94 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.43423287 |
| 95 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.42996170 |
| 96 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.42406651 |
| 97 | Spliceosome_Homo sapiens_hsa03040 | 0.41614568 |
| 98 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.40786987 |
| 99 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.40576070 |
| 100 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.40356008 |
| 101 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.40229659 |
| 102 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.39807769 |
| 103 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39151977 |
| 104 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.38663408 |
| 105 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.37903814 |
| 106 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.37854122 |
| 107 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.37652402 |
| 108 | ABC transporters_Homo sapiens_hsa02010 | 0.35717527 |
| 109 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.35543356 |
| 110 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.35532809 |
| 111 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.34909659 |
| 112 | Olfactory transduction_Homo sapiens_hsa04740 | 0.34416754 |
| 113 | Cell cycle_Homo sapiens_hsa04110 | 0.33428237 |
| 114 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.33253215 |
| 115 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.33051518 |
| 116 | Hepatitis B_Homo sapiens_hsa05161 | 0.32722127 |
| 117 | Prion diseases_Homo sapiens_hsa05020 | 0.32603644 |
| 118 | Lysine degradation_Homo sapiens_hsa00310 | 0.32551632 |
| 119 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.31328726 |
| 120 | Apoptosis_Homo sapiens_hsa04210 | 0.30420497 |
| 121 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.30408115 |
| 122 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.28792768 |
| 123 | Shigellosis_Homo sapiens_hsa05131 | 0.28334802 |
| 124 | Basal transcription factors_Homo sapiens_hsa03022 | 0.28267671 |
| 125 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.28109769 |
| 126 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.26372876 |
| 127 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.26250589 |
| 128 | Taste transduction_Homo sapiens_hsa04742 | 0.26097584 |
| 129 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.24961924 |
| 130 | Purine metabolism_Homo sapiens_hsa00230 | 0.24545067 |
| 131 | Viral myocarditis_Homo sapiens_hsa05416 | 0.24375095 |
| 132 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.24108574 |
| 133 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.23932815 |
| 134 | Endocytosis_Homo sapiens_hsa04144 | 0.23836517 |
| 135 | Homologous recombination_Homo sapiens_hsa03440 | 0.23742003 |
| 136 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.23573564 |
| 137 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.23210519 |
| 138 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.23199143 |
| 139 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.22451023 |
| 140 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.21978392 |
| 141 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.21877608 |
| 142 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.21088378 |
| 143 | Thyroid cancer_Homo sapiens_hsa05216 | 0.20426134 |
| 144 | RNA polymerase_Homo sapiens_hsa03020 | 0.20354990 |
| 145 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.18660492 |
| 146 | RNA degradation_Homo sapiens_hsa03018 | 0.18389393 |
| 147 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.17589446 |
| 148 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.16952733 |
| 149 | Influenza A_Homo sapiens_hsa05164 | 0.16768128 |

